3'-methoxy-2-thiomorpholinomethyl benzophenone, 97.0%, 1g

2-(2-(1H-Indol-3-yl)acetamido)pentanedioic acid, 97%, 5g

2-(Methylsulfonyl)pyrimidine-5-carbonitrile, 95.0%, 250mg

N,N,N',N'-Tetrakis(p-tolyl)benzidine (purified by sublimation)>98.0%(HPLC)(N)1g

Brij® 35, 500 g

2-Chlorobenzohydrazide>98.0%(GC)(T)25g

2-Methyl-1-propanol, min. 99%, for synthesis, 1 l, plastic packaging.

Graphene Nanoplatelets Aggregates (sub-micron particles, surface area 750m2/g)5g

(S)-3-Methoxypiperidine hydrochloride, 95.0%, 50g

2-Bromo-4-chloro-1-(chloromethyl)benzene, 97%, 100mg

8-Amino-6-chloro-4h-benzo[1,4]oxazin-3-one, 97%, 250mg

3-Fluorophenylglyoxal hydrate, 97.0%, 250mg

N-(3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-(trifluoromethyl)benzamide, 97%, 5g